Blockchain Registration Transaction Record

Nutriband's AVERSA Fentanyl Patch Hits Key Milestone, $15 Price Target Set

Nutriband Inc. achieves a milestone with AVERSA Fentanyl patch, setting a $15 price target. A breakthrough in abuse-deterrent technology with significant implications for drug abuse prevention.

The development of Nutriband's AVERSA Fentanyl patch is a critical step forward in addressing the opioid crisis by introducing an abuse-deterrent technology that could significantly reduce the potential for misuse and accidental exposure. This innovation not only has the potential to save lives but also positions Nutriband as a leader in the pharmaceutical industry's fight against drug abuse. The financial and regulatory progress highlighted in the report underscores the viability and importance of this technology, making it a noteworthy development for investors, healthcare professionals, and the general public alike.